Anika Therapeutics, Inc. (ANIK) Reports Q3 EPS of 22c
Tweet
Share
E-mailGet Alerts ANIK Hot Sheet
Price: $25.79 -0.62%
Revenue Growth %: +9.6%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
SFST, VLTO, CLIR, More
Revenue Growth %: +9.6%
Financial Fact:
Net income: 8.95M
Today's EPS Names:
SFST, VLTO, CLIR, More
Join SI Premium – FREE
Anika Therapeutics, Inc. (NASDAQ: ANIK) reported Q3 EPS of $0.22, vs. the analyst estimate of $0.11. Revenue for the quarter came in at $18.5 million versus the consensus estimate of $15.1 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Seagate Technology (STX) Tops Q3 EPS by 4c; offers Q4 guidance
- Visa (V) Tops Q2 EPS by 7c, offers guidance
- IDEX Corp. (IEX) Tops Q1 EPS by 13c ; Offers Guidance
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
